The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125401652 12540165 2 F 20160527 20160706 20160708 20160713 EXP FR-PFIZER INC-2016327822 PFIZER 50.00 YR M Y 0.00000 20160713 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125401652 12540165 1 PS Tazocilline PIPERACILLIN SODIUMTAZOBACTAM SODIUM 1 Intravenous (not otherwise specified) UNK Y 50750 INJECTION
125401652 12540165 2 SS BRICANYL TERBUTALINE SULFATE 1 Respiratory (inhalation) UNK Y 0
125401652 12540165 3 SS KEPPRA LEVETIRACETAM 1 Oral 500 MG, 1X/DAY 0 500 MG QD
125401652 12540165 4 SS URBANYL CLOBAZAM 1 Oral 10 MG, 1X/DAY 0 10 MG QD
125401652 12540165 5 SS AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Intravenous (not otherwise specified) 1 G, 3X/DAY Y 0 1 G TID
125401652 12540165 6 SS ATROVENT IPRATROPIUM BROMIDE 1 Respiratory (inhalation) UNK U 0
125401652 12540165 7 SS ROVAMYCIN SPIRAMYCIN 1 UNK Y 0
125401652 12540165 8 C TRIATEC /00116401/ ACETAMINOPHENCODEINE PHOSPHATE 1 0
125401652 12540165 9 C RETROVIR ZIDOVUDINE 1 0
125401652 12540165 10 C ORACILLIN /00001802/ PENICILLIN V POTASSIUM 1 0
125401652 12540165 11 C FUROSEMIDE. FUROSEMIDE 1 0
125401652 12540165 12 C VENTOLINE /00139501/ ALBUTEROL 1 UNK, AS NEEDED 0
125401652 12540165 13 C XATRAL ALFUZOSIN 1 10 MG, DAILY 0 10 MG
125401652 12540165 14 C UN ALFA ALFACALCIDOL 1 1 UG, DAILY 0 1 UG
125401652 12540165 15 C COUMADINE WARFARIN SODIUM 1 2 MG, DAILY 0 2 MG
125401652 12540165 16 C LEVOTHYROX LEVOTHYROXINE 1 75 UG, DAILY 0 75 UG
125401652 12540165 17 C CALCIDOSE VITAMINE D CALCIUMCHOLECALCIFEROL 1 500 MG, 3X/DAY 0 500 MG TID
125401652 12540165 18 C PARACETAMOL ACETAMINOPHEN 1 1 G, 3X/DAY 0 1 G TID
125401652 12540165 19 C ISENTRESS RALTEGRAVIR POTASSIUM 1 400 MG, 2X/DAY 0 400 MG BID
125401652 12540165 20 C TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 1 DF, DAILY 0 1 DF TABLET
125401652 12540165 21 C INEXIUM /01479302/ ESOMEPRAZOLE MAGNESIUM 1 20 MG, DAILY 0 20 MG

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
125401652 12540165 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125401652 12540165 Acute kidney injury
125401652 12540165 Cholestasis
125401652 12540165 Hepatocellular injury
125401652 12540165 Inflammation
125401652 12540165 Lactic acidosis
125401652 12540165 Rhabdomyolysis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125401652 12540165 1 20160528 0
125401652 12540165 2 20160527 20160530 0
125401652 12540165 5 20160527 20160530 0
125401652 12540165 6 20160528 0
125401652 12540165 7 20160528 20160530 0
125401652 12540165 13 20150824 0
125401652 12540165 14 20150824 0
125401652 12540165 15 20150824 0
125401652 12540165 16 20150824 0
125401652 12540165 17 20150824 0
125401652 12540165 18 20150824 0
125401652 12540165 19 20150824 0
125401652 12540165 20 20150824 0
125401652 12540165 21 20150824 0